Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Obesity

• Publication date

  2009-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/oby.2009.102PMID 19360006PMCID PMC4683159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

  2008influential reference
• Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.

  2008cited by this paper
• Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.

  2008influential reference
• Gastrointestinal surgery as treatment for type 2 diabetes

  2008cited by this paper
• Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

  2008influential reference
• High body mass index for age among US children and adolescents, 2003-2006.

  2008cited by this paper
• Identification of Human Hepatic Cytochrome P450 Enzymes Involved in the Biotransformation of Cholic and Chenodeoxycholic Acid

  2008cited by this paper
• Prevention and Treatment of Obesity, Insulin Resistance, and Diabetes by Bile Acid–Binding Resin

  2007cited by this paper
• Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

  2007cited by this paper
• Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program: A Randomized Trial

  2007cited by this paper
• Lipid and Bile Acid Analysis

  2006cited by this paper
• Endocrine functions of bile acids

  2006cited by this paper
• Deiodinases: implications of the local control of thyroid hormone action.

  2006cited by this paper
• Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

  2006cited by this paper
• Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function

  2006cited by this paper
• Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation

  2006influential reference
• Peptide YY Levels Are Elevated After Gastric Bypass Surgery

  2006cited by this paper
• Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man

  2006cited by this paper
• Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

  2005cited by this paper
• Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.

  2005cited by this paper
• Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats.

  2005cited by this paper
• Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

  2005cited by this paper
• Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.

  2004cited by this paper
• Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

  2004cited by this paper
• Bariatric surgery: a systematic review and meta-analysis.

  2004cited by this paper
• Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes

  2004cited by this paper
• Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

  2003cited by this paper
• Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.

  2002cited by this paper
• Bowel habits and bile acid malabsorption in the months after cholecystectomy

  2002cited by this paper
• Ileal transposition into the upper jejunum affects lipid and bile salt absorption in rats.

  1996cited by this paper
• Long‐term effects of cholecystectomy on bile acid metabolism

  1995cited by this paper
• Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

  1994cited by this paper
• Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon.

  1993cited by this paper
• Increased plasma glucagon-like immunoreactivity in dogs with ileojejunal transposition.

  1990cited by this paper
• Internal biliary diversion improves glucose tolerance in the rat.

  1985cited by this paper
• Cholestyramine treatment reduces postprandial but not fasting serum bile acid levels in humans.

  1982cited by this paper
• Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum.

  1982cited by this paper
• Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance

  1979cited by this paper
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

  1979cited by this paper
• Evidence for the absorption of bile acids in the proximal small intestine of normo- and hyperlipidaemic subjects.

  1976cited by this paper

• Impacto de la cirugía bariátrica sobre la microbiota intestinal y el perfil metabolómico del eje enterohepático en un modelo experimental de obesidad

  2026cites this paper
• Hypothalamic malate dehydrogenase 2 modulates systemic glucose metabolism through oxytocin-mediated thermogenesis.

  2026cites this paper
• Metabotherapy for intestinal disease: using metabolites to prevent and treat disorders of the gut.

  2026cites this paper
• Efficacy and safety of single-anastomosis gastric bypass variants versus sleeve gastrectomy or Roux-en-Y gastric bypass: a systematic review and meta-analysis.

  2026cites this paper
• Transforming NAFLD Management: The Role of Bile Acid Changes Post-Vertical Sleeve Gastrectomy.

  2026cites this paper
• Intestinal rearrangement of biliopancreatic limbs, alimentary limbs, and common limbs in obese type 2 diabetic mice after duodenal jejunal bypass surgery

  2025cites this paper
• Transforming Treatment: The Impact of Bariatric Surgery on Oral Drug Absorption.

  2025cites this paper
• The Effect of Cholecystectomy on Weight Loss after Metabolic Bariatric Surgery

  2025cites this paper
• Beyond weight loss: exploring the neurological ramifications of altered gut microbiota post-bariatric surgery

  2025cites this paper
• The Gut Microbiota–Metabolic Axis: Emerging Insights from Human and Experimental Studies on Type 2 Diabetes Mellitus—A Narrative Review

  2025cites this paper
• Metabolomic Alterations in Patients with Obesity and the Impact of Metabolic Bariatric Surgery: Insights for Future Research

  2025cites this paper
• Unresolved alterations in bile acid composition and dyslipidemia in maternal and cord blood after UDCA treatment for intrahepatic cholestasis of pregnancy.

  2025cites this paper
• Fexaramine as the intestine-specific farnesoid X receptor agonist: A promising agent to treat obesity and metabolic disorders.

  2025cites this paper
• Profile of Serum Bile Acids in Elderly Type 2 Diabetic Patients with Various Obesity Types: A Cross-Sectional Study

  2025cites this paper
• Diabetes remission and diabetic complications of bariatric surgery vs. medical management in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials

  2025cites this paper
• Alterations in intestinal bile acid transport provide a therapeutic target in patients with post-bariatric hypoglycaemia

  2025cites this paper
• Clinical Significance of Early Postoperative Weight Loss in Bariatric Surgery: A Narrative Review

  2025cites this paper
• Bariatric and Metabolic Surgery for Type 2 Diabetes Reversal—Weighing Risks and Benefits

  2025cites this paper
• Gut enteroendocrine cell activation using a combination of GPR119 and GPR40 agonists results in synergistic hormone secretion in mice and humans.

  2025cites this paper
• Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development

  2024cites this paper
• Dynamics of the human bile acid metabolome during weight loss

  2024cites this paper
• Unresolved alterations in bile acid composition and dyslipidemia in maternal and cord blood after ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy

  2024cites this paper
• Gastric Bypass vs Diet and Cardiovascular Risk Factors

  2024cites this paper
• Variant of the lactase LCT gene explains association between milk intake and incident type 2 diabetes

  2024cites this paper
• Cholelithiasis, Gut Microbiota and Bile Acids after Bariatric Surgery—Can Cholelithiasis Be Prevented by Modulating the Microbiota? A Literature Review

  2024cites this paper
• Longitudinal Profiling of Fasting Plasma Metabolome in Response to Weight-Loss Interventions in Patients with Morbid Obesity

  2024cites this paper
• Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches

  2024cites this paper
• Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies

  2024cites this paper
• Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management—A Narrative Review

  2024cites this paper
• Postprandial metabolomics analysis reveals disordered serotonin metabolism in post-bariatric hypoglycemia

  2024influential citation
• A small intestinal bile acid modulates the gut microbiome to improve host metabolic phenotypes following bariatric surgery.

  2024cites this paper
• New Lessons from the gut: studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy.

  2024cites this paper
• Circulating biomarker profile changes in obese patients undergoing bariatric surgery

  2024cites this paper
• Bariatric and Metabolic Surgery for Diabesity: A Narrative Review

  2024cites this paper
• Investigating regional-specific gut microbial distribution: an uncharted territory in disease therapeutics

  2024cites this paper
• Gastrointestinal complaints after Roux-en-Y gastric bypass surgery. Impact of microbiota and its metabolites

  2024cites this paper
• Mechanism of action and selection of endoscopic bariatric therapies for treatment of obesity

  2024cites this paper
• Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis.

  2024cites this paper
• Vertical Sleeve Gastrectomy Reduces Gut Luminal Deoxycholic Acid Concentrations in Mice

  2024cites this paper
• Patented Farnesoid X receptor modulators: a review (2019 – present)

  2024cites this paper
• Mechanism of metabolic surgery for the treatment of Type 2 Diabetes Mellitus (T2DM)

  2023cites this paper
• Thyme Extract Alleviates High-Fat Diet-Induced Obesity and Gut Dysfunction

  2023cites this paper
• Postbariatric surgery hypoglycemia: Nutritional, pharmacological and surgical perspectives

  2023cites this paper
• The long‐term effect of bariatric/metabolic surgery versus pharmacologic therapy in type 2 diabetes mellitus patients: A systematic review and meta‐analysis

  2023cites this paper
• The emerging role of bile acids in white adipose tissue.

  2023cites this paper
• Prognostic factors in resolution of nonalcoholic fatty liver disease post bariatric surgery in adolescents.

  2023cites this paper
• How can we pharmacologically mimic the mechanisms that make gastric bypass so effective? Are we close to a "medical bypass"?

  2023cites this paper
• Preservation of β-Cells as a Therapeutic Strategy for Diabetes

  2023cites this paper
• Noninvasive Colorectal Cancer Screening in Bariatric Surgery Patients As a Viable Option to Increase Uptake

  2023cites this paper
• Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009–2020

  2023cites this paper
• Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease

  2023cites this paper
• CYP8B1 downregulation mediates the metabolic effects of vertical sleeve gastrectomy in mice

  2023cites this paper
• Differential effects of bariatric surgery and caloric restriction on hepatic one-carbon and fatty acid metabolism

  2023cites this paper
• Are elevated systemic bile acids involved in the pathophysiology of sarcopenia and liver injury following gastric bypass?

  2023cites this paper
• Effect of sleeve gastrectomy and Roux-en-Y gastric bypass on gastrointestinal physiology.

  2023cites this paper
• Remission of type 2 diabetes: A critical appraisal

  2023cites this paper
• The impact of microbially modified metabolites associated with obesity and bariatric surgery on antitumor immunity

  2023cites this paper
• Extension Region Domain of Soybean 7S Globulin Contributes to Serum Triglyceride-Lowering Effect via Modulation of Bile Acids Homeostasis.

  2023cites this paper
• A multiomics comparison of weight loss interventions shows the distinct effects of bariatric surgery and intermittent fasting on hepatic metabolism

  2022cites this paper
• Gut Factors Mediating the Physiological Impact of Bariatric Surgery

  2022cites this paper
• Regulation of body weight: Lessons learned from bariatric surgery

  2022cites this paper
• A view at postbariatric hypoglycemia by endocrinologist

  2022cites this paper
• Farnesoid X receptor activation by the novel agonist TC-100 (3α, 7α, 11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid) preserves the intestinal barrier integrity and promotes intestinal microbial reshaping in a mouse model of obstructed bile acid flow.

  2022cites this paper
• Metabolic Profile and Metabolite Analyses in Extreme Weight Responders to Gastric Bypass Surgery

  2022cites this paper
• [Hypothalamic bile acid-TGR5 signaling: A therapeutic target in the fight against obesity?]

  2022cites this paper
• The Effect and Mechanism of Duodenal-Jejunal Bypass to Treat Type 2 Diabetes Mellitus in a Rat Model

  2022cites this paper
• Neurohormonal Changes in the Gut–Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery

  2022cites this paper
• Molecular Gatekeeper Discovery: Workflow for Linking Multiple Exposure Biomarkers to Metabolomics.

  2022cites this paper
• Metabolic Messengers: bile acids

  2022cites this paper
• Hepatic steatosis changes after early gastric cancer surgery

  2022cites this paper
• Mechanisms and Outcomes of Metabolic Surgery in Type 2 Diabetes

  2022cites this paper
• Decreased Weight Loss Following Bariatric Surgery in Patients with Type 2 Diabetes

  2022influential citation
• The impact of bariatric surgery on colorectal cancer risk.

  2022cites this paper
• Mucosal and hormonal adaptations after Roux-en-Y gastric bypass.

  2022cites this paper
• Asociación de los niveles de ácidos biliares y hormonas tiroideas en la colestasis intrahepática del embarazo

  2022cites this paper
• Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease Atherosclerosis.

  2022cites this paper
• Impact of bariatric surgery on circulating PCSK9 levels as a marker of cardiovascular disease risk: a meta-analysis

  2022cites this paper
• Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats

  2022cites this paper
• Bile acids, gut microbiota and metabolic surgery

  2022cites this paper
• Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV

  2022cites this paper
• Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia

  2022cites this paper
• Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?

  2021cites this paper
• Physiologic Mechanisms of Weight Loss Following Metabolic/Bariatric Surgery.

  2021cites this paper
• The role of bariatric surgery in the management of nonalcoholic steatohepatitis

  2021cites this paper
• Inhibitors of the Apical Sodium-Dependent Bile Acid Transporter (ASBT) as Promising Drugs

  2021cites this paper
• FXR‐mediated epigenetic regulation of GLP‐1R expression contributes to enhanced incretin effect in diabetes after RYGB

  2021cites this paper
• Metabolites and diabetes remission after weight loss

  2021cites this paper
• Bile acids and their receptors in metabolic disorders.

  2021cites this paper
• Hypothyroidism and levothyroxine therapy following bariatric surgery: a systematic review, meta-analysis, network meta-analysis, and meta-regression.

  2021cites this paper
• Changes in fasting bile acid profiles after Roux-en-Y gastric bypass and sleeve gastrectomy

  2021cites this paper
• Restored TDCA and valine levels imitate the effects of bariatric surgery

  2021cites this paper
• Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study

  2021cites this paper
• Who will benefit from bariatric surgery for diabetes? A protocol for an observational cohort study

  2021cites this paper
• Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass.

  2021cites this paper
• Hypothalamic bile acid-TGR5 signaling protects from obesity.

  2021cites this paper
• Mechanisms of Action of Different Bariatric Surgical Procedures

  2021cites this paper
• Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5

  2021cites this paper
• Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling

  2021cites this paper
• NPC1L1 Deficiency Suppresses Ileal Fibroblast Growth Factor 15 Expression and Increases Bile Acid Pool Size in High-Fat-Diet-Fed Mice

  2021cites this paper
• Is Obesity/Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second Generation Medications.

  2021cites this paper